Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.8.0.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 06, 2018
Mar. 05, 2018
Feb. 14, 2018
Feb. 09, 2018
Jan. 31, 2018
Oct. 05, 2017
Sep. 21, 2017
Feb. 22, 2017
Feb. 07, 2017
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Mar. 07, 2017
Bad debts reserve                   $ 591,323      
Sales revenue                   2,191,983      
Revenue                   $ 1,600,000      
Reserve stock split, description             1-for-15 reverse stock split effective October 5, 2017   1-for-30 reverse stock split of the Company’s shares of common stock effective on February 22, 2017        
Common stock conversion description           Every 15 shares of the Company’s then outstanding common stock was combined and automatically converted into one share   As a result of the Reverse Stock Splits, every 30 shares of the Company;s then outstanding common stock was combined and automatically converted into one share          
Common stock par value           $ 0.01     $ 0.01 $ 0.01   $ 0.01  
Common stock shares authorized                 500,000,000 3,000,000,000   3,000,000,000  
Preferred stock shares authorized                 5,000,000 5,000,000   5,000,000  
Derivative liability                     $ 56,000,000    
Reversal of interest expense                   41,000,000    
Deemed dividend, down round feature                   53,300,000      
Deemed dividend                     $ 51,000,000    
Working capital deficit                   174,800,000      
Stockholders' deficit                   183,907,626   $ 40,613,461  
Proceeds from issuance debentures                   2,000,000   15,700,000  
Revenue earned for services                   15,000,000      
Cash acquired from acquisition                   635,000      
Estimated acquisition cost                   500,000      
Total cost of acquisition                   $ 1,100,000      
Number of shares issued                   286,240,000      
March 2018 Offering [Member]                          
Debt maturity date   Sep. 19, 2019                      
Principal amount   $ 2,480,000                      
Proceeds from offering   $ 2,000,000                      
Nano Vibronix Inc [Member]                          
Number of shares issued     200,000                    
Share issued price per share     $ 4.00                    
Series I-2 Convertible Preferred Stock [Member]                          
Preferred stock shares authorized                   5,000,000      
Debt maturity date       Sep. 19, 2019                  
Principal amount       $ 1,384,556                  
Number of shares issued       1,731                  
Seamus Lagan [Member]                          
Number of compensation shares issued 26,666,667                        
Dr. Kamran Ajami [Member]                          
Number of compensation shares issued 3,333,333                        
John Beach [Member]                          
Number of compensation shares issued 3,333,333                        
Gary L. Blum [Member]                          
Number of compensation shares issued 3,333,333                        
Christopher Diamantis [Member]                          
Number of compensation shares issued 3,333,333                        
Principal amount                         $ 500,000
Trevor Langley [Member]                          
Number of compensation shares issued 3,333,333                        
Employees and Directors [Member]                          
Number of compensation shares issued 71,333,331                        
Asset Purchase Agreement [Member]                          
Acquisition on assets, description         The purchase was completed on June 1, 2018. The hospital was acquired by a newly formed subsidiary, Jamestown TN Medical Centre, Inc. and is an 85-bed facility of approximately 90,000 square feet on over eight acres of land, which offers a 24-hour Emergency Department with two spacious trauma bays and seven private exam rooms, inpatient and outpatient medical services and a Progressive Care Unit which provides telemetry services.                
May 30 2018 [Member]                          
Accrued interest and extension fees                   $ 7,800,000      
Debt fee amount received                   $ 100,000      
May 9 2018 [Member]                          
Common stock shares authorized                   3,000,000,000      
May 9, 2018 [Member] | Minimum [Member]                          
Common stock shares authorized                   500,000,000      
May 9, 2018 [Member] | Maximum [Member]                          
Common stock shares authorized                   3,000,000,000      
Additional Paid-in Capital [Member]                          
Discount on convertible debenture                   $ 16,000,000      
Stockholders' deficit                   $ (126,619,959)   $ (128,351,954)